EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer
Clinical trial NCT02183870 · COMPLETED
Trial details
- NCT number
- NCT02183870
- Sponsor
- University of Cologne
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2018-07-24
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.